EUVIMEDEUVIMED entdecken
Crossref

Pan-Drug Resistant Klebsiella Pneumoniae — An Emerging Threat In Clinical Microbiology-A Case Series.

IOSR Journal of Dental and Medical Sciences · 2026-07 · 25 (7) · 68-71

DOI: 10.9790/0853-2507016871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-07.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major healthcare-associated pathogen with limited therapeutic options. Colistin, widely used as salvage therapy for carbapenem-resistant Enterobacterales, is increasingly compromised by emerging resistance. This case series describes the clinical profile, microbiological characteristics, antimicrobial susceptibility pattern, and outcomes of colistin-resistant CRKP infections identified in a tertiary-care centre. Four clinically significant cases of colistin-resistant CRKP were identified retrospectively, including two cases of ventilator-associated pneumonia, one orthopaedic wound infection, and one neonatal bloodstream infection. Organism identification and antimicrobial susceptibility testing were performed using standard microbiological methods and confirmed by VITEK2. Colistin minimum inhibitory concentration was determined by broth microdilution method. All isolates were resistant to carbapenems and colistin (MIC 4–8 μg/mL), while tigecycline retained in-vitro activity against all isolates. Three patients improved following tigecycline-based therapy and were discharged, whereas one elderly patient with severe sepsis and multiorgan dysfunction succumbed to illness. The emergence of colistin-resistant CRKP represents a serious therapeutic and infection control challenge, indicating progression toward extensively drugresistant or pan-drug-resistant phenotypes. Early microbiological detection using reliable colistin susceptibility testing methods, strict infection prevention practices, and robust antimicrobial stewardship are essential to limit further emergence and spread of these organisms.

Zitieren

APA

(2026). Pan-Drug Resistant Klebsiella Pneumoniae — An Emerging Threat In Clinical Microbiology-A Case Series. IOSR Journal of Dental and Medical Sciences, 25(7), 68-71. https://doi.org/10.9790/0853-2507016871

Vancouver

Pan-Drug Resistant Klebsiella Pneumoniae — An Emerging Threat In Clinical Microbiology-A Case Series. IOSR Journal of Dental and Medical Sciences. 2026;25(7):68-71. doi:10.9790/0853-2507016871

BibTeX
@article{euvimed2026,
  title = {Pan-Drug Resistant Klebsiella Pneumoniae — An Emerging Threat In Clinical Microbiology-A Case Series},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {7},
  pages = {68--71},
  doi = {10.9790/0853-2507016871}
}
Kostenlos starten →